维普中文期刊产品整合服务
40篇 您的检索式:作者名="Sculpher M"
    题名 作者 年代 出处 被引量
1Cetuximab plus radiotherapy for the treatment of locally advanced squamous cell carcinoma of the head and neck显示文摘Griffin S Walker S Sculpher M 2009Health Technol Assess2009,131,:1
2An introduction to Markov modelling for economic evaluation显示文摘BRIGGS A SCULPHER M 1998Pharmacoeconomics1998,13,4:1
3Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: re- suits from a randomized trial显示文摘Sculpher M Manca A Abbott J 2004BMJ2004,328,7432:1
4Generalisability in economic evaluation studies in healthcare: a review and case studies 显示文摘SCULPHER M J PANG F S MANCA A 2004Health Technol Assess2004,8,49:1
5Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery 显示文摘Sculpher M J Dwyer N Byford S 1996Br J Obset Gynaecol1996,103,2:1
6Generalisability in economic e- valuation studies in healthcare: a review and case studies显示文摘Sculpher M Pang F Manca A 2004Health Technol Asses2004,8,49:1
7Bayesian methods for evidence synthesis in cost-effectiveness analysis 显示文摘Ades AE Sculpher M Sutton A 2006Pharmacoeconomics2006,24,1:1
8Cetuximab plus radiotherapy for the treatment of locally advanced squamous cell carcinoma of the head and neck显示文摘Griffin S Walker S Sculpher M 2009Health Technol Assess2009,13,1:1
9Low doses vs high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure:a cost-effectiveness analysis based on the assessment of treatment with lisinopril and survival (ATLAS) study显示文摘Sculpher M J Poole L Cleland J 0,,:1
10Modelling thecost - effec- tiveness of cardiac interventions: The case ofsirolimus - eluting stents显示文摘Hawkins N Sculpher M Rothman M 2005Br J Cardial2005,,12:1
11Common methodological flaws in economic evaluations 显示文摘Drummond M Sculpher M 2005Med Care2005,43,7:1
12Fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-ef- fectiveness using data from the fifth organization to assess strategies in acute ischemic syndromes investigators (OA- SIS-5) tfial显示文摘Sculpher M J Lozano-Ortega G Sambrook J 2009Am Heart J2009,157,5:1
13Value-based pricing to ensure cost effective drugs for the UK NHS:will it work? 显示文摘Sculpher M 2013Clinical Thera- peutics2013,35,8:1
14Modelling of cost- effectiveness of THR: methods and results and discussion in primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses显示文摘Fitzpatrick R Shortall E Sculpher M 1998Health Technol Assess1998,2,20:1
15Representing uncertainty: The role of cost-effectiveness acceptability curves 显示文摘Fenwick E Claxton K Sculpher M 2001Health Econ2001,10,8:1
16Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra 显示文摘Claxton K Sculpher M McCabe C 2005Health Economics2005,14,:1
17A rational framework for decision making by the National Institute for Clinical Excellence (NICE)显示文摘Claxton K Sculpher M Drummond M 2002The Lancel2002,360,:1
18A rational framework for decision making by the National Institute For Clinical Excellence (NICE)显示文摘Claxton K Sculpher M Drummond M 2002Lancet2002,360,9334:1
19An introduction to Markov modelling for economic evaluation显示文摘Briggs A Sculpher M 1998Pharmaco Economics1998,13,4:1
20Patient characteristics impacting health state index scores, measured by the EQ-5D of females with stress urinary incontinence symptoms 显示文摘Tincello D Sculpher M Tunn R etal 2010Value Health2010,13,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费